Another question thatwas addressed was the impact of IL-6 on the responses of the MM lines to PPARγ antagonists, since this is a cytokine thatplays a central role in the pathogenesis and progression of MM, as well asother cancer types. The gene discussed is PPARG; the disease is Miyoshi myopathy.